These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24118291)

  • 1. Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
    Vironneau P; Kania R; Morizot G; Elie C; Garcia-Hermoso D; Herman P; Lortholary O; Lanternier F;
    Clin Microbiol Infect; 2014 May; 20(5):O336-9. PubMed ID: 24118291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhino-orbito-cerebral mucormycosis.
    Thomas PA; Geraldine P
    Indian J Ophthalmol; 2004 Jun; 52(2):171-2; author reply 172. PubMed ID: 15283230
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis--early diagnosis and treatment.
    Guevara N; Roy D; Dutruc-Rosset C; Santini J; Hofman P; Castillo L
    Rev Laryngol Otol Rhinol (Bord); 2004; 125(2):127-31. PubMed ID: 15462174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy.
    Thajeb P; Thajeb T; Dai D
    Scand J Infect Dis; 2004; 36(9):643-8. PubMed ID: 15370650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhino-orbital-cerebral mucormycosis. A retrospective analysis and treatment option.
    Betharia SM; Wagh VB; Pathak H; Sharma V
    Indian J Ophthalmol; 2004 Mar; 52(1):82; author reply 82-3. PubMed ID: 15132392
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal rhino-orbito-cerebral zygomycosis caused by Apophysomyces elegans in a healthy patient.
    Schütz P; Behbehani JH; Khan ZU; Ahmad S; Kazem MA; Dhar R; Eskaf W; Hamed HH; Cunningham LL
    J Oral Maxillofac Surg; 2006 Dec; 64(12):1795-802. PubMed ID: 17113448
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B.
    Alobid I; Bernal M; Calvo C; Vilaseca I; Berenguer J; Alós L
    Am J Rhinol; 2001; 15(5):327-31. PubMed ID: 11732820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rhino-orbito-cerebral mucormycosis].
    Trabelsi S; Marrakchi J; Aloui D; Lahiani R; Sellami A; Ben Salah M; Ferjaoui M; Khaled S
    Tunis Med; 2013 Feb; 91(2):164-5. PubMed ID: 23526289
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.
    Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK
    Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature.
    Garcia-Covarrubias L; Bartlett R; Barratt DM; Wassermann RJ
    J Trauma; 2001 Feb; 50(2):353-7. PubMed ID: 11242306
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic versus non-diabetic rhino-orbito-cerebral mucormycosis.
    Abdolalizadeh P; Kashkouli MB; Khademi B; Karimi N; Hamami P; Es'haghi A
    Mycoses; 2020 Jun; 63(6):573-578. PubMed ID: 32191363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction.
    Kofteridis DP; Karabekios S; Panagiotides JG; Bizakis J; Kyrmizakis D; Saridaki Z; Gikas A
    J Chemother; 2003 Jun; 15(3):282-6. PubMed ID: 12868556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.
    Haliloglu NU; Yesilirmak Z; Erden A; Erden I
    Dentomaxillofac Radiol; 2008 Mar; 37(3):161-6. PubMed ID: 18316508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes.
    Bhansali A; Bhadada S; Sharma A; Suresh V; Gupta A; Singh P; Chakarbarti A; Dash RJ
    Postgrad Med J; 2004 Nov; 80(949):670-4. PubMed ID: 15537854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.